| 1 |
Mutations of cytochrome c identified in patients with thrombocytopenia THC4 affect both apoptosis and cellular bioenergetics.
6
56
61
|
De Rocco D...Savoia A
|
24326104 |
2014 |
| 2 |
A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.
56
6
|
Uchiyama Y...Mizuguchi T
|
30051457 |
2018 |
| 3 |
A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia.
56
6
|
Morison IM...Ledgerwood EC
|
18345000 |
2008 |
| 4 |
A new piroplasmid species infecting dogs: morphological and molecular characterization and pathogeny of Babesia negevi n. sp.
61
|
Baneth G...Aroch I
|
32312309 |
2020 |
| 5 |
Phase II study of bevacizumab, cisplatin, and pemetrexed in advanced non-squamous non-small cell lung cancer (NS-NSCLC) with EGFR wild-type.
61
|
Murakami S...Yamada K
|
31881129 |
2019 |
| 6 |
Naturally Occurring A51V Variant of Human Cytochrome c Destabilizes the Native State and Enhances Peroxidase Activity.
61
|
Lei H...Bowler BE
|
31557440 |
2019 |
| 7 |
Efficacy and safety of preoperative 5-fluorouracil, cisplatin, and mitomycin C in combination with radiotherapy in patients with resectable and borderline resectable pancreatic cancer: a long-term follow-up study.
61
|
Endo Y...Kitagawa Y
|
31420046 |
2019 |
| 8 |
Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with 177Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.
61
|
Heck MM...Eiber M
|
30473431 |
2019 |
| 9 |
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
61
|
Oudard S...Elaidi R
|
30703190 |
2019 |
| 10 |
Phase II study of carboplatin, pemetrexed, and bevacizumab in advanced nonsquamous non-small-cell lung cancer.
61
|
Laslett NF...Guarino M
|
29905018 |
2018 |
| 11 |
Combined Fluoroscopy and Ultrasound-Guided Transjugular Kidney Biopsy in Cirrhotic Patients.
61
|
Bashir S...Sarin SK
|
29576494 |
2018 |
| 12 |
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
61
|
Gleeson M...Cunningham D
|
29703335 |
2018 |
| 13 |
Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study.
61
|
Roulot D...ANRS HC32 QUATTRO study group
|
29271782 |
2018 |
| 14 |
A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.
61
|
Spencer A...Richardson P
|
29076150 |
2018 |
| 15 |
Risk of hematologic toxicities with programmed cell death-1 inhibitors in cancer patients: a meta-analysis of current studies.
61
|
Sui JD...Wu YZ
|
29922039 |
2018 |
| 16 |
Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma.
61
|
Duerinck J...Neyns B
|
28988341 |
2018 |
| 17 |
Thymus transplantation for complete DiGeorge syndrome: European experience.
61
|
Davies EG...Thrasher AJ
|
28400115 |
2017 |
| 18 |
A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
61
|
Kuronya Z...Geczi L
|
28074331 |
2017 |
| 19 |
A 15-year single centre retrospective study of antiphospholipid syndrome patients from Northern Malaysia.
61
|
Islam MA...Wong KK
|
28866693 |
2017 |
| 20 |
Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer.
61
|
Jang J...Shin JW
|
28341958 |
2017 |
| 21 |
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.
61
|
Hill P...Webster AC
|
28073178 |
2017 |
| 22 |
Megakaryocytes from CYCS mutation-associated thrombocytopenia release platelets by both proplatelet-dependent and -independent processes.
61
|
Ong L...Ledgerwood EC
|
27861742 |
2017 |
| 23 |
Outcomes of first line chemotherapy in patients with chronic lymphocytic leukemia.
61
|
Nazir A...Hameed A
|
27882024 |
2016 |
| 24 |
Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-July 7, 2016.
61
|
Adams L...Rivera-Garcia B
|
27490087 |
2016 |
| 25 |
Increased dynamics in the 40-57 Ω-loop of the G41S variant of human cytochrome c promote its pro-apoptotic conformation.
61
|
Karsisiotis AI...Worrall JA
|
27461282 |
2016 |
| 26 |
Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders.
61
|
Jensen D...HALLMARK-QUAD Study Team
|
25703086 |
2015 |
| 27 |
Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response.
61
|
Yeo W...Yu SC
|
25962426 |
2015 |
| 28 |
Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study.
61
|
Brana I...Calvo E
|
24928772 |
2015 |
| 29 |
Non-transient "self-sustaining" heparin-induced thrombocytopenia: 4-year persistence of a platelet-activating PF4/heparin-antibody status without heparin exposure.
61
|
Birschmann I...Koster A
|
24246163 |
2014 |
| 30 |
Evaluation of the safety of imatinib mesylate in 200 iraqi patients with chronic myeloid leukemia in the chronic phase: single-center study.
61
|
Matti BF...Alwan AF
|
24385829 |
2013 |
| 31 |
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: a Children's Oncology Group phase 1 consortium study.
61
|
Hummel TR...Blaney SM
|
23554030 |
2013 |
| 32 |
A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors.
61
|
Strosberg JR...Kulke MH
|
23572164 |
2013 |
| 33 |
Gemcitabine plus capecitabine in unselected patients with advanced pancreatic cancer.
61
|
Hubner RA...Chau I
|
23462324 |
2013 |
| 34 |
Evaluation of vinorelbine-based chemotherapy as the second or further-line treatment in patients with metastatic breast cancer.
61
|
Cybulska-Stopa B...Brandys A
|
23788967 |
2013 |
| 35 |
[Inherited paternal antigens induce pregnancy thrombocytopenia].
61
|
Xia JY...Wu XQ
|
23257447 |
2012 |
| 36 |
Chemosensitized radiosurgery for recurrent brain metastases.
61
|
Roberge D...Pouliot JF
|
22910852 |
2012 |
| 37 |
Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma.
61
|
Wada H...Iwatsuki K
|
22506596 |
2012 |
| 38 |
Severe Plasmodium vivax malaria among sudanese children at New Halfa Hospital, Eastern Sudan.
61
|
Mahgoub H...Adam I
|
22846165 |
2012 |
| 39 |
Irinotecan plus mitomycin C as second-line chemotherapy for advanced gastric cancer resistant to fluoropyrimidine and Cisplatin: a retrospective study.
61
|
Ogawa K...Sugiyama T
|
22474446 |
2012 |
| 40 |
Mitomycin C in combination with vinorelbine in anthracycline- and/or taxane-pretreated patients with metastatic breast cancer.
61
|
Schippert C...Luck HJ
|
23007147 |
2012 |
| 41 |
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia.
61
|
Silva F...Taborda A
|
22679192 |
2011 |
| 42 |
Platinum-based doublet chemotherapy in pre-treated malignant pleural mesothelioma (MPM) patients: a mono-institutional experience.
61
|
Pasello G...Favaretto A
|
21296448 |
2011 |
| 43 |
Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
61
|
Xu Y...Qiu G
|
21056507 |
2011 |
| 44 |
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer.
61
|
Kanai M...Hatano E
|
20811895 |
2011 |
| 45 |
Initial cytoreductive treatment with thalidomide plus bolus vincristine/doxorubicin and reduced dexamethasone followed by autologous stem cell transplantation for multiple myeloma.
61
|
Jo JC...Suh C
|
19823768 |
2011 |
| 46 |
Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.
61
|
Nogue M...AVACROSS Study Group
|
21467148 |
2011 |
| 47 |
Mutations in the 5' UTR of ANKRD26, the ankirin repeat domain 26 gene, cause an autosomal-dominant form of inherited thrombocytopenia, THC2.
61
|
Pippucci T...Balduini CL
|
21211618 |
2011 |
| 48 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early results.
61
|
Semrau S...Fietkau R
|
21234526 |
2011 |
| 49 |
Sunitinib malate for gastrointestinal stromal tumour in imatinib mesylate-resistant patients: recommendations and evidence.
61
|
Younus J...Sarcoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care
|
20697509 |
2010 |
| 50 |
Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors.
61
|
Ramanathan RK...Belani CP
|
20177028 |
2010 |
